Clinical Trial Update: Internet-based, Naturalistic Evaluation of Tolerability and Individual Patient Target Pressures With Bimatoprost 0.03% in Glaucoma

View source ↗

Summary

An internet-based, naturalistic evaluation of tolerability for bimatoprost 0.03% in open-angle glaucoma has been completed, providing real-world tolerability da…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma Open-angle

Drugs mentioned

• Bimatoprost 0.03% (bimatoprost)

Snippet

Sponsor: Allergan | Conditions: Glaucoma, Open-Angle | Status: COMPLETED